VibioSphen (FR)

https://www.vibiosphen.com

VibioSphen is a SME healthcare biotechnology in infectious diseases founded in 2014. It focuses its activities on the challenge of antibiotic resistance and nosocomial infections. To meet this goal VibioSphen proposes a dual business model with two complementary activities: service offer (CRO, Contract Research Organization), with a large panel of optimized preclinical infectious models (bacteria, fungi and virus) and Research & Innovation (R&I) to develop new immune modulator treatments complementary to antibiotics. Vibiosphen combines expertise in microbiology, molecular biology and pharmacology (in vitro and in vivo) with experience in drug R&D in the field of infectious diseases, immunomodulation and host-pathogen interaction. As a biotechnology company, we conduct research into potential future therapies against multi-resistant bacteria (Escherichia coli, Pseudomonas aeruginosa, Klebsiella, Acinetobacter, Staphylococcus aureus.;.) with a portfolio of 4 promising immunomodulatory pre-candidates and provide services drawing on cutting-edge technology to create predictive and translational models (pneumonia, Urinary Tract Infection, septicemia…) for studying small molecules or biologics. VibioSphen is currently completing his portfolio with natural products. These two activities complement and drive each other in terms of research and innovation. Our team has extensive experience in the field of infectious diseases in the pharmaceutical industry. By pooling complementary skills, our team provides the highest level of technical expertise in producing predictive pharmacological models and anticipates the requirements for the development of a new molecule. *

	Start	2014-01-01 established
	Industry	anti-infective drug
	Industry 2	contract research (drugs)

	Region	Labège
	Country	France
	Street	516 Rue Pierre et Marie Curie Prologue Biotech
	City	31670 Labège
	Tel	+33-5-6128-7031
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«:

		Record changed: 2024-02-12

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]